Protein-Templated Core/Shell Au Nanostructures for Intracellular Reactive Oxygen Species Detection by SERS
Source abstract
Abstract
Core/shell gold “raspberry” nanostructures capable of multiple therapeutic functionalities were synthesized using a template composed of monodispersed anionic protein (bovine serum albumin) nanoparticles coated with a cationic biopolymer (poly-l-lysine). The nanostructures exhibited high photothermal conversion efficiency when exposed to a near-infrared (NIR) laser, which led to significant cellular inhibition of A549 human lung cancer cells due to intracellular hyperthermia. The raspberry structures also provided hot spots for surface-enhanced Raman scattering (SERS) ratiometric sensing of intracellular reactive oxygen species (ROS) when modified with the Raman reporter molecule 4-aminothiophenol (4-ATP). ROS was detected in A549 lung cancer cells upon photothermal heating of internalized nanostructures, enabling a possible mechanism for feedback on therapeutic efficacy. This was confirmed by adding the antioxidant N-acetylcysteine (NAC) and using a complementary fluorescence technique, which showed that the amount of detectable intracellular ROS decreased. These safe-by-design gold raspberry nanostructures could be promising for simultaneous therapeutic applications and monitoring therapeutic efficacy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering, University of Rhode Island, 2 East Alumni Avenue, Kingston, South Kingstown, Rhode Island 02881, United States
Department of Biomedical and Pharmaceutical Science, University of Rhode Island, 7 Greenhouse Road, Kingston, South Kingstown, Rhode Island 02881, United States
Funding
National Heart, Lung, and Blood Institute · Office of Integrative Activities · National Institute of General Medical Sciences
References (62)
Show source-provided references
1. 10.1002/adhm.20200180610.1002/adhm.202001806 ↗
2. 10.1039/D0BM00222D10.1039/D0BM00222D ↗
3. 10.1038/s41467-018-03473-910.1038/s41467-018-03473-9 ↗
4. 10.1021/acsami.0c1146910.1021/acsami.0c11469 ↗
5. 10.1016/j.canlet.2008.04.02610.1016/j.canlet.2008.04.026 ↗
6. 10.1038/srep1170910.1038/srep11709 ↗
7. 10.1021/acsnano.0c0879010.1021/acsnano.0c08790 ↗
8. 10.1021/acsnano.7b0687010.1021/acsnano.7b06870 ↗
9. 10.1002/anie.20200300410.1002/anie.202003004 ↗
10. 10.1038/s41467-020-15427-110.1038/s41467-020-15427-1 ↗
11. 10.1016/j.jare.2010.02.00210.1016/j.jare.2010.02.002 ↗
12. 10.1039/D0RA08689D10.1039/D0RA08689D ↗
13. 10.1021/acsnano.8b0144010.1021/acsnano.8b01440 ↗
14. 10.1007/s10853-021-05947-610.1007/s10853-021-05947-6 ↗
15. 10.1016/j.cej.2021.12974410.1016/j.cej.2021.129744 ↗
16. 10.1021/acsami.9b1885510.1021/acsami.9b18855 ↗
17. 10.1038/s41598-021-88909-x10.1038/s41598-021-88909-x ↗
18. 10.1021/acs.biomac.6b0072110.1021/acs.biomac.6b00721 ↗
19. 10.1039/D1TB00823D10.1039/D1TB00823D ↗
20. 10.1021/acsami.6b1323710.1021/acsami.6b13237 ↗
21. 10.1021/acsnano.8b0960710.1021/acsnano.8b09607 ↗
22. 10.1039/C6NR03459D10.1039/C6NR03459D ↗
23. 10.1021/acsami.7b1678410.1021/acsami.7b16784 ↗
24. 10.1021/acsnano.6b0665110.1021/acsnano.6b06651 ↗
25. 10.1016/j.ijbiomac.2020.10.09110.1016/j.ijbiomac.2020.10.091 ↗
26. 10.1021/acs.chemrev.8b0062610.1021/acs.chemrev.8b00626 ↗
27. 10.1038/s41419-020-2317-310.1038/s41419-020-2317-3 ↗
28. 10.3390/ijms2116559810.3390/ijms21165598 ↗
29. 10.1038/cddis.2016.10510.1038/cddis.2016.105 ↗
30. 10.1155/2013/94291610.1155/2013/942916 ↗
31. 10.1038/nchem.150010.1038/nchem.1500 ↗
32. 10.1007/s00249-001-0202-210.1007/s00249-001-0202-2 ↗
33. 10.1021/ac503636j10.1021/ac503636j ↗
34. 10.1002/asia.20200134010.1002/asia.202001340 ↗
35. 10.1007/s00216-020-03045-110.1007/s00216-020-03045-1 ↗
36. 10.1038/s41467-021-21570-010.1038/s41467-021-21570-0 ↗
37. 10.1021/acs.analchem.8b0311610.1021/acs.analchem.8b03116 ↗
38. 10.1039/C6CC03412H10.1039/C6CC03412H ↗
39. 10.1002/ange.20181267710.1002/ange.201812677 ↗
40. 10.1021/acssensors.1c0039510.1021/acssensors.1c00395 ↗
41. 10.1021/acs.analchem.6b0137810.1021/acs.analchem.6b01378 ↗
42. 10.3390/biomedicines901007410.3390/biomedicines9010074 ↗
43. 10.1039/D0TB00377H10.1039/D0TB00377H ↗
44. 10.1021/acsnano.8b0453310.1021/acsnano.8b04533 ↗
45. 10.1039/C7NR05316A10.1039/C7NR05316A ↗
46. 10.1021/acs.molpharmaceut.8b0094810.1021/acs.molpharmaceut.8b00948 ↗
47. 10.1021/acsabm.9b0079710.1021/acsabm.9b00797 ↗
48. 10.1038/ncomms1319310.1038/ncomms13193 ↗
49. 10.1038/nmeth.208910.1038/nmeth.2089 ↗
50. 10.1038/s41598-021-84131-x10.1038/s41598-021-84131-x ↗
51. 10.1016/j.ijpharm.2021.12042210.1016/j.ijpharm.2021.120422 ↗
52. 10.1016/S0378-5173(99)00370-110.1016/S0378-5173(99)00370-1 ↗
53. 10.1016/j.colsurfb.2019.11053410.1016/j.colsurfb.2019.110534 ↗
54. 10.1002/cplu.20190074510.1002/cplu.201900745 ↗
55. 10.1038/s41598-016-0028-x10.1038/s41598-016-0028-x ↗
56. 10.1007/s10973-020-09597-910.1007/s10973-020-09597-9 ↗
57. 10.1002/anie.20121035910.1002/anie.201210359 ↗
58. 10.1021/acsami.5b0830510.1021/acsami.5b08305 ↗
59. 10.1021/ac200467z10.1021/ac200467z ↗
60. 10.1016/0162-0134(84)85007-210.1016/0162-0134(84)85007-2 ↗
61. 10.1016/j.snb.2018.08.06810.1016/j.snb.2018.08.068 ↗
62. 10.3390/bios1102003010.3390/bios11020030 ↗